Literature DB >> 10729375

The role of plaque rupture and thrombosis in coronary artery disease.

A G Zaman1, G Helft, S G Worthley, J J Badimon.   

Abstract

Atherosclerosis and its thrombotic complications are the major cause of morbidity and mortality in the industrialized world. The progression of atherosclerotic plaques in the coronary circulation is dependent on several risk factors. It is now clear that plaque composition is a major determinant of the risk of subsequent plaque rupture and superimposed thrombosis. The vulnerability of plaques to rupture is further determined by extrinsic triggering factors. Following rupture, the fatty core of the plaque and its high content of tissue factor provide a powerful substrate for the activation of the coagulation cascade. Plaque rupture can be clinically silent or cause symptoms of ischaemia depending on thrombus burden and the degree of vessel occlusion. In addition, plaque rupture and subsequent healing is recognized to be a major cause of further rapid plaque progression. This review looks at the mechanisms underlying the development and progression of atherosclerotic plaques, factors leading to plaque rupture and subsequent thrombosis and their clinical consequences. Finally, we speculate on targets for future research.

Entities:  

Mesh:

Year:  2000        PMID: 10729375     DOI: 10.1016/s0021-9150(99)00479-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  55 in total

1.  Controllable inhibition of cellular uptake of oxidized low-density lipoprotein: structure-function relationships for nanoscale amphiphilic polymers.

Authors:  Nicole M Iverson; Sarah M Sparks; Bahar Demirdirek; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Acta Biomater       Date:  2010-02-17       Impact factor: 8.947

2.  Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging.

Authors:  Tobias Saam; Chun Yuan; Baocheng Chu; Norihide Takaya; Hunter Underhill; Jianming Cai; Nam Tran; Nayak L Polissar; Blazej Neradilek; Gail P Jarvik; Carol Isaac; Gwenn A Garden; Kenneth R Maravilla; Beverly Hashimoto; Thomas S Hatsukami
Journal:  Atherosclerosis       Date:  2006-09-15       Impact factor: 5.162

Review 3.  [Haemostaseology].

Authors:  K Schrör
Journal:  Internist (Berl)       Date:  2005-08       Impact factor: 0.743

Review 4.  Optical coherence tomography for imaging the vulnerable plaque.

Authors:  Guillermo J Tearney; Ik-Kyung Jang; Brett E Bouma
Journal:  J Biomed Opt       Date:  2006 Mar-Apr       Impact factor: 3.170

Review 5.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

6.  Association of endothelin-converting enzyme-1b C-338A polymorphism with increased risk of ischemic stroke in Chinese Han population.

Authors:  Rui Li; Min Cui; Jin Zhao; Mingming Yu; Zegang Ying; Shiming Zhou; Huadong Zhou
Journal:  J Mol Neurosci       Date:  2013-09-13       Impact factor: 3.444

7.  Relation of plaque size to compositions as determined by an in vivo volumetric intravascular ultrasound radiofrequency analysis.

Authors:  Ze-Sheng Xu; Byoung Kwon Lee; Duk-Woo Park; Seung-Whan Lee; Young-Hak Kim; Cheol Whan Lee; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2009-10-23       Impact factor: 2.357

8.  Patterns of β-blocker initiation in patients undergoing intermediate to high-risk noncardiac surgery.

Authors:  Elisabetta Patorno; Shirley V Wang; Sebastian Schneeweiss; Jun Liu; Brian T Bateman
Journal:  Am Heart J       Date:  2015-07-26       Impact factor: 4.749

Review 9.  Is atherosclerosis regression a realistic goal of statin therapy and what does that mean?

Authors:  Mukesh Singh; Updesh Singh Bedi
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

Review 10.  Myocardial infarction, stroke, and sudden cardiac death may be prevented by influenza vaccination.

Authors:  David G Meyers
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.